We can't find the internet
Attempting to reconnect
18269.2 PFLS-LS
A novel, localized approach to immune checkpoint modulation for the therapy of cancer
Résumé
A novel, localized approach to immune checkpoint modulation for the therapy of cancer
Textes supplémentaires
Abstract
The pathophysiology of chronic inflammation and epithelial cancer are casuatively linked. Interleukin (IL)-23 and IL-23 receptor (IL23R) expressing cells are heavily implicated in the development of various malignancies. In this project the potential of a bispecific antibody fragment specifically depleting IL23R expressing cells shall be evaluated to reactivate the host anti-cancer immune response.
Participants
David Urech
Wirtschaftspartner
d.urech@numab.com
Numab AG David Urech Einsiedlerstrasse 34 8820 Wädenswil ZH CH
Burkhard Becher
Kontaktperson
becher@immunology.uzh.ch
Universität Zürich Burkhard Becher Winterthurerstrasse 190 8057 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-04-30
- Date de fin
- 2019-04-30
- Coûts totaux approuvés
- CHF 433563.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%